CAS RN: 100037-69-2

PIPES sesquisodium salt

  • Product code: SSC-000175
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 100g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 100037-69-2
Pack Size Recorded Purity Available Qty Ship From Inquiry
100g ≥95% 0 Out of Stock Shanghai Inquiry

100037-69-2 / trisodium;2-[4-(2-sulfoethyl)piperazin-1-yl]ethanesulfonate;2-[4-(2-sulfonatoethyl)piperazin-1-yl]ethanesulfonate

100037-69-2 | 1,4-Piperazinediethanesulfonic acid, sodium salt (2:3) | 1,4-Piperazinediethanesulfonic acid sesquisodium salt

Standard CAS: 100037-69-2 Multi CAS: Yes

Basic Information

CAS
100037-69-2
Multi CAS
Yes
Molecular Formula
C16H33N4Na3O12S4
Molecular Weight
670.700000
Exact Mass
670.067090
SMILES
C1CN(CCN1CCS(=O)(=O)O)CCS(=O)(=O)[O-].C1CN(CCN1CCS(=O)(=O)[O-])CCS(=O)(=O)[O-].[Na+].[Na+].[Na+]
InChI
InChI=1S/2C8H18N2O6S2.3Na/c2*11-17(12,13)7-5-9-1-2-10(4-3-9)6-8-18(14,15)16;;;/h2*1-8H2,(H,11,12,13)(H,14,15,16);;;/q;;3*+1/p-3
InChIKey
FPDACHMSOMILQI-UHFFFAOYSA-K
Synonyms
100037-69-2 1,4-Piperazinediethanesulfonic acid, sodium salt (2:3) 1,4-Piperazinediethanesulfonic acid sesquisodium salt DTXSID50142888 RefChem:73381

Computed Properties

Structural Parameters

Heavy atom count
39
Fraction Csp3
1
Rotatable bonds
12
H-bond acceptors
15
H-bond donors
1
Molar refractivity
125.87
TPSA
238.93

LogP / Solubility

WLOGP
-13.26
MLOGP
-11.61
XLogP3
-13.26
Consensus LogP
-12.71
Log S (ESOL)
5.15
Class (ESOL)
Highly soluble
Log S (Ali)
4.51
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
5.54
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-16.22

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
4

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us